NCT05641662 Effects of Exergaming to Reduce Sedentary Time in Inactive Patients With Heart Failure
| NCT ID | NCT05641662 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Linkoeping University |
| Condition | Cardiovascular Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 750 participants |
| Start Date | 2022-05-16 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 750 participants in total. It began in 2022-05-16 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this to determine the effect of tailored exergaming for inactive patients with heart failure to reduce their sedentary time, improve their daily physical activity, exercise capacity, decrease frailty and improve health-related quality of life. Participants will, on a background of standard guideline-directed medical therapy patients, be randomised to tailored activity advice (control) or the Heart-Exergame (Heart-eXg) intervention for a period of 3 months. Patients randomised to the Heart-eXg group will receive an exergame with feedback and tailoring to adapt the exergaming advice. Patients will also be able to play with a person in their own network.
Eligibility Criteria
Inclusion Criteria: 1. Diagnosed with symptomatic HF (NYHA II-IV) as diagnosed by cardiologist, (independent of Ejection Fraction: Patients with a preserved ejection fraction (HFpEF), mid-range ejection fraction (HFmrREF) or reduced ejection fraction (HFrEF) can be included. 2. Clinically stable 3. Physically inactive 4. Older than 18 years, there is no upper age limit, 5. Speak/understand the language of the country where the study is taking place. 6. Wanting to use a smartphone for the study (if patients do not have a smartphone, they can borrow it from the study team for the duration of the study) Exclusion Criteria: 1. Unable to use an exergame due to visual, hearing, cognitive impairment assessed by HF nurse or cardiologist. 2. Not being able to perform the 6-minute walk test. 3. Not being able or willing to wear an activity monitor. 4. Currently included in a rehabilitation program 5. Lack of willingness to play an exergame. 6. Co-morbidity that hinders benefitting for this form of exercise (history of stroke, severe cognitive dysfunction, or a life expectancy shorter than 6 months).
Contact & Investigator
Tiny Jaarsma, PhD
PRINCIPAL INVESTIGATOR
Linkoeping University
Frequently Asked Questions
Who can join the NCT05641662 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiovascular Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05641662 currently recruiting?
Yes, NCT05641662 is actively recruiting participants. Contact the research team at tiny.jaarsma@liu.se for enrollment information.
Where is the NCT05641662 trial being conducted?
This trial is being conducted at Porto, Portugal, Košice, Slovakia, Barcelona, Spain, Barcelona, Spain and 8 additional locations.
Who is sponsoring the NCT05641662 clinical trial?
NCT05641662 is sponsored by Linkoeping University. The principal investigator is Tiny Jaarsma, PhD at Linkoeping University. The trial plans to enroll 750 participants.